12 ex-FDA leaders criticize claims made by agency's current vaccine chief
Bullish
50.0
The former officials said the FDA's plans to revamp how certain life-saving vaccines are handled would "disadvantage the people the FDA exists to protect, including millions of Americans at high risk from serious infections."
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
